Hjem › Hjertesvigt › Nebraska › Omaha
Hjertesvigt kliniske forsøg i Omaha, NE
13 studier for Hjertesvigt søger deltagere på steder i og omkring Omaha (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RekruttererFase 3
- Be Well Clinical Studies, Omaha
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RekruttererFase 3
- University of Nebraska Medical Center, Omaha
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Rekrutterer
- University of Nebraska Medical Center, Omaha
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RekruttererFase 3
- Research Site, Omaha
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
RekruttererFase 3
- CON-10018, Omaha, NE, Omaha
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruttererFase 3
- Omaha, NE Investigative Site 10018, Omaha
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- University of Nebraska Medical Center, Omaha
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RekruttererObservationsstudie
- Omaha, Omaha
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RekruttererObservationsstudie
- CHI Health Reseach Center, Omaha
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RekruttererFase 3
- Tenax Investigational Site, Omaha
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- University of Nebraska Medical Center, Omaha
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Rekrutterer
- University of Nebraska Medical Center, Omaha
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
RekruttererFase 4
- Creighton University Medical Center, Omaha
Hjertesvigt forsøg i andre byer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Houston, TX36 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- St. Louis, MO26 studier
- Durham, NC26 studier
- Kansas City, MO25 studier
- Atlanta, GA25 studier
Andre studier i Omaha
- Prostatakræft27 studier
- Ikke-småcellet lungecancer24 studier
- Brystkræft22 studier
- Colorektal kræft18 studier
- Kræft (alle typer)18 studier
- Multipelt myelom16 studier
- Non-Hodgkin lymfom14 studier
- Ægstockræft14 studier
- Bugspytkirtelkræft14 studier
- Pladecellekræft i hoved og hals13 studier
- Metastatisk cancer13 studier
- Nyrekancer (renocellulært karcinom)12 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.